Sign in
8-K

Current Report

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-22-222823

Executive or director change · Regulation FD disclosure · Other events

  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading d390683d8k.htm…